Pharmaceutical - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

226 to 250 of 641 results

GVK BIO to acquire US CRO Aragen Bioscience


Asia’s leading small-molecule contract research organization (CRO), GVK BIO, has reached agreement…

Aragen BioscienceBiosimilarsGVK BIOMergers & AcquisitionsPharmaceutical

Medigene acquires Trianta Immunotherapies


Germany’s Medigene this morning revealed that it has acquired 100% of the shares of the Munich-based…

MedigeneMergers & AcquisitionsOncologyPharmaceuticalTrianta ImmunotherapiesVaccines

McKesson back on track to secure acquisition of Celesio


US health care services and information technology firm McKesson Corp says that it has reached an agreement…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds


German pharma and life sciences group Bayer says it is taking advantage of currently low interest rates…

AlgetaBayerFinancialMergers & AcquisitionsPharmaceutical

NuPathe accepts Teva’s higher counter bid, rejecting Endo offer


Israel-based Teva Pharmaceutical Industries seems set to bag ownership of US drugmaker NuPathe), which…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalTeva Pharmaceutical IndustriesZecuity

Growing Indian pharma market provides incentives for foreign acquisitions


A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Russian pharma market on verge of further consolidation in 2014


The Russian pharmaceutical market is on the verge of new deals and acquisitions in 2014, after a record…

Eastern EuropeMergers & AcquisitionsPharmaceuticalRussia

Indian government proceeds with FDI policy, despite warnings

Indian government proceeds with FDI policy, despite warnings


Overlooking concerns about the scarcity of generic drugs in the domestic market given the spate of multinationals…

Asia-PacificIndiaMergers & AcquisitionsPharmaceuticalPolitics

Johnson & Johnson offered $4.15 billion for its diagnostics unit

Johnson & Johnson offered $4.15 billion for its diagnostics unit


After days of speculation about divestitures by US health care major Johnson & Johnson, the company last…

Johnson & JohnsonMergers & AcquisitionsPharmaceutical

Moderna spins-out Onkaido Therapeutics to focus on mRNA therapeutics in oncology


Flush with cash as a result of its mega-million dollar deal with Alexion on the development of drugs…

Mergers & AcquisitionsModerna TherapeuticsOncologyOnkaido TherapeuticsPharmaceuticalResearch

Biotoscana to buy United Medical to create regional specialty pharma group in South America


Colombia-based Grupo Biotoscana has signed an agreement to acquire Brazilian drugmaker United Medical…

Grupo BiotoscanaMergers & AcquisitionsPharmaceuticalSouth AmericaUnited Medical

McKesson acquisition of German rival Celesio fails


USA-based health care service and information technology giant McKesson Corp revealed yesterday that…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

Galena Biopharma acquires Mills Pharmaceuticals


US drugmaker Galena Biopharma revealed that it has acquired Mills Pharmaceuticals, which has the worldwide…

AnagrelideGalena BioPharmaHematologyMergers & AcquisitionsMills PharmaceuticalsPharmaceutical

Big pharma's need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive, says EY


Big pharma stayed on the sidelines in the 2013 mergers and acquisitions market despite a continuing need…

GlobalMergers & AcquisitionsPharmaceutical

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher


Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Akorn gains rights to Betimol from Santen


US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Endo divests remainder of HealthTronics for up to $130 million


Endo Health Solutions says it has entered into a definitive agreement to sell its HealthTronics business…

Endo Health SolutionshealthTronicsMergers & AcquisitionsPharmaceutical

NuPathe receives counter offer from Teva topping Endo bid


US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

Forest Labs to spend $2.9 billion on acquiring Aptalis

Forest Labs to spend $2.9 billion on acquiring Aptalis


Confirming recent speculative reports, US drugmaker Forest Laboratories says it has entered into a definitive…

AptalisForest LaboratoriesGastro-intestinalsMergers & AcquisitionsPharmaceuticalRare diseases

Eddingpharm acquires global rights to oncology assets, including telatinib, from ACT Biotech


Chinese drug firm Eddingpharm has entered into an asset purchase agreement (APA) with a private, venture…

ACT BiotechEddingpharmMergers & AcquisitionsOncologyPharmaceuticaltelatinib

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

Probiodrug sells its CDK9 inhibitor program to AstraZeneca


Privately-held German company Probiodrug says it has transferred its experimental cyclin-dependent kinase…

AstraZenecaInflammatory diseasesMergers & AcquisitionsOncologyPharmaceuticalProbiodrug

NeXeption forms new company, Alexar Therapeutics, to develop novel LXR agonist portfolio


US biopharma management company NeXeption says it has secured $21.5 million in Series A financing to…

A-110Alexar TherapeuticsDermatologicalsFinancialMergers & AcquisitionsNeXeptionPharmaceuticalResearch

Ikaria sells commercial business to Madison Dearborn for $1.6 billion


US critical care company Ikaria says that its investor group and employee shareholders have reached a…

IkariaInomaxMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

226 to 250 of 641 results



Back to top